How much funding has ACOM Labs raised?

ACOM Labs has raised $25.0M in total funding, most recently a Series A round.

Who are ACOM Labs's investors?

ACOM Labs's investors include Atomic, Foresite Capital, Polaris Partners.

Where is ACOM Labs headquartered?

ACOM Labs is headquartered in United States.

What industry is ACOM Labs in?

ACOM Labs operates in Biotech, Healthcare.

ACOM Labs

Innovative device-enabled therapeutics for at-home dermatological care

United States · $25.0M raised

Biotech

Healthcare

Employees: 1–10
Business Model: B2B
Total Funding: $25.0M

Last Round: $25.0M Series AOct 2025
Rounds: 1

About

ACOM Labs, doing business as Indomo, is a clinical-stage therapeutics company dedicated to expanding access to quality healthcare through innovative device-enabled drug delivery. The company is developing DT-001, a drug-device combination candidate that pairs triamcinolone acetonide with the ClearPen™ — a novel intradermal self-injection device — to enable fast-acting at-home treatment of inflammatory acne lesions. Indomo's model transforms in-office dermatological procedures into self-administered patient care, addressing limited access to clinic-based treatments.

Summary

ACOM Labs is a Biotech company based in United States. It has raised $25.0M in total across 1 round, most recently a $25.0M Series A round in Oct 2025. Investors include Atomic, Foresite Capital and Polaris Partners.